| Product Code: ETC7659414 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pneumococcal Polysaccharide Vaccine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pneumococcal Polysaccharide Vaccine Market - Industry Life Cycle |
3.4 Israel Pneumococcal Polysaccharide Vaccine Market - Porter's Five Forces |
3.5 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.6 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Pneumococcal Polysaccharide Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases |
4.2.2 Growing government initiatives to promote immunization programs |
4.2.3 Rising prevalence of pneumococcal infections in Israel |
4.3 Market Restraints |
4.3.1 High cost associated with the vaccine |
4.3.2 Limited accessibility of vaccines in remote areas |
4.3.3 Concerns about vaccine safety and efficacy |
5 Israel Pneumococcal Polysaccharide Vaccine Market Trends |
6 Israel Pneumococcal Polysaccharide Vaccine Market, By Types |
6.1 Israel Pneumococcal Polysaccharide Vaccine Market, By Dosage |
6.1.1 Overview and Analysis |
6.1.2 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Dosage, 2021- 2031F |
6.1.3 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Single Dose Vial, 2021- 2031F |
6.1.4 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Pre-Filled Syringe, 2021- 2031F |
6.2 Israel Pneumococcal Polysaccharide Vaccine Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Children (2-10 Age), 2021- 2031F |
6.2.3 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Adult (10-64 Age), 2021- 2031F |
6.2.4 Israel Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Geriatric (More Than 65 Age), 2021- 2031F |
7 Israel Pneumococcal Polysaccharide Vaccine Market Import-Export Trade Statistics |
7.1 Israel Pneumococcal Polysaccharide Vaccine Market Export to Major Countries |
7.2 Israel Pneumococcal Polysaccharide Vaccine Market Imports from Major Countries |
8 Israel Pneumococcal Polysaccharide Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates |
8.2 Number of government-funded vaccination campaigns |
8.3 Rate of reported pneumococcal infections in Israel |
8.4 Number of healthcare facilities offering the vaccine |
8.5 Patient satisfaction with vaccination services |
9 Israel Pneumococcal Polysaccharide Vaccine Market - Opportunity Assessment |
9.1 Israel Pneumococcal Polysaccharide Vaccine Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.2 Israel Pneumococcal Polysaccharide Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Pneumococcal Polysaccharide Vaccine Market - Competitive Landscape |
10.1 Israel Pneumococcal Polysaccharide Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Israel Pneumococcal Polysaccharide Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here